Effect of Vit C in severe pneumonia
Phase 3
- Conditions
- Effects of vitamin C administration in patients mortality with severe pneumonia in ICU.Sepsis due to Streptococcus pneumoniaeA40.3
- Registration Number
- IRCT20190312043030N1
- Lead Sponsor
- Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
All patients who have been diagnosed with severe pneumonia criteria
Exclusion Criteria
Patients who are not able to survive for more than 24 hours because of end-stage or clinical deterioration
Patients with their own dissatisfaction or the inability to obtain informed consent from the patient or family of patients
Patients under the age of 18 and over
Patients who have had warfarin use 24 hours before study
Patients who received up to 48 hours prior to admission Undetermined vitamin C
Patients with bleeding disorders
Patients with G6PD deficiency
Patients with primary creatinine above 1.5
Patients with a history of kidney oxalate stones
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Frequency of mortality. Timepoint: 28 days mortality rate. Method of measurement: Sequential organ failure Assessment score.
- Secondary Outcome Measures
Name Time Method